MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Patient Community Day at ECTRIMS 2025
  • Multiple Sclerosis in 2025 – Key Developments to Date
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
two doctors, a man and a woman, examine an MRI image of the brain

FDA Decision On Tolebrutinib

MStranslate
January 12, 2026
Clinical Trials
A pair of hands around a crystal ball that has the year 2026 written inside it.

Multiple Sclerosis Research In 2026

MStranslate
January 5, 2026
Progressive MS, Remyelination, Treatments
ECTRIMS Congress 2025

Revisiting ECTRIMS Congress 2025

MStranslate
November 18, 2025
ECTRIMS, Podcasts, Research
The ECTRIMS Podcast

UPDATED: The ECTRIMS Podcast – Episode Library

MStranslate
September 10, 2025
ECTRIMS, Podcasts, Research
Patient Community Day

Patient Community Day at ECTRIMS 2025

MStranslate
July 22, 2025
ECTRIMS, Events, Research
ECTRIMS 2019

ECTRIMS 2019: Review of Online Coverage

MStranslate
September 18, 2019
Conferences, ECTRIMS
While ECTRIMS 2019 is officially over, our coverage of it will continue during the coming weeks.  There are three reasons for this.  Firstly, there was just too much content to cover in our short end of day...
ECTRIMS 2019

ECTRIMS 2019: Final Thoughts From Stockholm

MStranslate
September 13, 2019
Dr Travis Stiles, ECTRIMS, Research
ECTRIMS 2019 has officially ended.  It is safe to say that it was a huge three days and I am exhausted!  I really hope that you have enjoyed the video summaries from Day 1 and Day 2.  With the conference...
Quality of Life

Improving Quality of Life in Multiple Sclerosis

MStranslate
August 28, 2019
Quality of Life, Research, Symptoms
2 Comments
Recently, I arrived in the United Kingdom and headed north to the city of Liverpool.  While I’m a fan of The Beatles and a passionate Liverpool Football Club supporter in the Premier League, I had other...
Facebook Live

Facebook Live: Announcement & Research Update

MStranslate
August 16, 2019
Community, Q&A, Research
In our most recent Facebook Live Q&A, once again facilitated by our co-founder and chief science communicator, Brett Drummond, a special announcement was made. We were excited to share that, for the second...
MS: Many Stories

MS: Many Stories – Managing MS Through Lifestyle

MStranslate
August 2, 2019
Community, MS: Many Stories
1 Comment
It is fantastic to once again be able to revisit our MS: Many Stories series, where members of the MStranslate community share their personal insights and experiences of living with multiple sclerosis.  This...
cognition

Does Age of MS Onset Impact on Cognition?

MStranslate
June 26, 2019
Cognition, Research, Symptoms
1 Comment
Research Summary: Long-term Cognitive Outcomes in Patients With Pediatric-Onset vs Adult-Onset Multiple Sclerosis Ask people living with multiple sclerosis what their worst symptom is and they will probably...
body mass index

Body Mass Index (BMI) Linked to Brain Volume Loss

MStranslate
June 18, 2019
Lifestyle, Research
There is an increasing focus on the role that lifestyle changes may play in helping to manage multiple sclerosis. Factors such as diet, exercise, mindfulness, vitamin D levels and smoking habits are all...
World MS Day

Facebook Live: World MS Day Research Update

MStranslate
June 11, 2019
Research, Videos
On World MS Day 2019 (May 29), MStranslate co-founder and chief science communicator, Brett Drummond, took to Facebook Live to provide a comprehensive update on the latest developments in multiple sclerosis...
gut bacteria

Treatment With Gut Bacteria Shows Benefits In New Study

MStranslate
May 2, 2019
Research, Treatments
1 Comment
Research Summary: Prevotella histicola, A Human Gut Commensal, Is as Potent as COPAXONE® in an Animal Model of Multiple Sclerosis Many people living with multiple sclerosis say they have experienced...
stem cells

Stem Cells in Hair Follicles Show Myelin Repair Potential

MStranslate
April 30, 2019
Remyelination, Research, Stem Cells
Research Summary: CD34 defines melanocyte stem cell subpopulations with distinct regenerative properties Myelin repair or remyelination is considered by many, including an overwhelming majority of our...
  1. 6
  2. 7
  3. 8
  4. 9
  5. 10
  6. 11
  7. 12

Recent Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Recent Comments

  • FDA Decision On Tolebrutinib - MStranslate on Multiple Sclerosis in 2025 – Key Developments to Date
  • Treatment With Gut Bacteria Shows Benefits In New Study on Gut Bacteria in People Living with RRMS
  • Community Q&A: COVID-19 Vaccines & Multiple Sclerosis on Community Q&A: The Blood-Brain Barrier
  • Community Q&A: Why Don't We Have A Multiple Sclerosis Cure? on Community Q&A: COVID-19 Vaccines & MS
  • Tim Little on FAKE NEWS ALERT: COVID Vaccines & MS

Calendar

March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
« Jan    

Archives

Categories

Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.